How to get approved for Saxenda Once you and your healthcare provider decide that you will start treatment with Saxenda, you may be eager to start the medicine and lose weight
On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said
In December 2014, it was deemed a suitable option for chronic weight management in addition to a calorie reduced diet and physical activity
FDA Notice Statements on this website have not been evaluated by the Food and Drug Administration
Note: Compounded semaglutide and tirzepatide from licensed 503A pharmacies follow similar clinical frameworks as brand medications but are prescribed off-label in pediatric settings
Biochemical and histological parameters: ALT, alanine aminotransferase
